Syneron Medical, a leading global esthetic device company, announced recently that the U.S. Food and Drug Administration (FDA) cleared its new PicoWay picosecond device. The system was evaluated in a U.S. multicenter study conducted by Eric Bernstein, M.D., president of Main Line Center for Laser Surgery (Ardmore, PA), Arielle Kauvar, M.D., director of New York Laser & Skin Care, and Tina Alster, M.D., founding director of Washington Institute of Dermatologic Laser Surgery, and showed a favorable safety profile. This dual wavelength laser utilizes proprietary technology to generate picosecond (one trillionth of a second) pulses for the safe removal of tattoos. It is approved for all tattoo colors: red, yellow, and orange for the 532nm wavelength, and black, brown, green, blue, and purple for the 1064nm wavelength. In the study, a majority of participants achieved at least 50 percent tattoo clearance after three treatments. “PicoWay is an innovative and exciting breakthrough for tattoo removal,” says Bernstein. “It delivers extremely high peak-power, picosecond pulses enabling the treatment of all skin types. What this means is extremely impressive results, which translate into very happy patients. PicoWay is a game-changing laser for tattoo removal and could not have come at a better time.”—Jennifer Nied